Anorexia Nervosa and Brain in Adolescence
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Aims of this follow-up study are to investigate effects of anorexia nervosa on brain structure and functions in adolescence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2024
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2024
CompletedFirst Posted
Study publicly available on registry
April 23, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
April 23, 2024
April 1, 2024
5.9 years
April 5, 2024
April 18, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Neuroimaging
Transcranial magnetic stimulation (TMS) combined with electroencephalogram (EEG)
Baseline and at 3 years' follow-up
Secondary Outcomes (1)
Neuroimaging
Baseline and at 3 years' follow-up
Other Outcomes (3)
Psychiatric evaluation
Baseline and at 3 years' follow-up
Body composition measurement
Baseline and at 3 years' follow-up
Laboratory tests
Baseline and at 3 years' follow-up
Study Arms (2)
Study group
Adolescents diagnosed with anorexia nervosa or atypical anorexia nervosa.
Control Group
Healthy adolescents.
Interventions
Neuroimaging, body compostion, laboratory tests and psychiatric interview in study and in control groups.
Eligibility Criteria
Target study population is 50 participants. Study group (25 participants) are recruited from North Savo wellbeing services, Adolescent psychiatry outpatient clinic. Control group (25 participants) are recruited from Kuopio restrict lower and upper secondary schools.
You may qualify if:
- Control group : 1) age 16-19 years, 2) BMI over 19.0, 3) No lifetime obesity (BMI over 30) nor eating disorder.
You may not qualify if:
- \) glucose metabolism disorder or any chronic medical disorder, or medicine with possible effects on neurotransmitters, 2) previous mental health problem (excluded anorexia nervosa or atypical anorexia nervosa in study group), 3) smoking, nicotine products, alcohol or any other substance abuse or dependence, 4) contraindication for used brain imaging method.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Virve Kekkonen, M.D.
Kuopio University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist in adolescent psychiatry, clinical lecturer
Study Record Dates
First Submitted
April 5, 2024
First Posted
April 23, 2024
Study Start
September 1, 2024
Primary Completion (Estimated)
August 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
April 23, 2024
Record last verified: 2024-04